EBITDA for Charles River (CRL)
According to Charles River's latest reported financial statements, the company's current EBITDA (TTM) is $801.38M USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$801.38M
YoY change
+56.8%
5Y CAGR
+3.5%
Peak year (2023)
$1.03B
Cumulative EBITDA
$9.76B
EBITDA history chart for Charles River (CRL) from 1998 to 2025
EBITDA history table for Charles River (CRL) from 1998 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $911.15M | +56.8% | ||
| 2024 | $581.14M | -43.7% | ||
| 2023 | $1.03B | +4.7% | ||
| 2022 | $986.15M | +20.2% | ||
| 2021 | $820.16M | +6.7% | ||
| 2020 | $768.47M | +36.5% | ||
| 2019 | $563.06M | +11.0% | ||
| 2018 | $507.23M | +10.8% | ||
| 2017 | $457.89M | +21.4% | ||
| 2016 | $377.29M | +23.5% | ||
| 2015 | $305.38M | +6.8% | ||
| 2014 | $285.99M | +11.7% | ||
| 2013 | $255.93M | +4.7% | ||
| 2012 | $244.36M | -6.2% | ||
| 2011 | $260.48M | -227.0% | ||
| 2010 | -$205.15M | -177.9% | ||
| 2009 | $263.20M | -174.0% | ||
| 2008 | -$355.82M | -210.6% | ||
| 2007 | $321.81M | +17.7% | ||
| 2006 | $273.30M | -0.5% | ||
| 2005 | $274.81M | +36.1% | ||
| 2004 | $201.92M | +19.0% | ||
| 2003 | $169.67M | +14.7% | ||
| 2002 | $147.99M | +24.5% | ||
| 2001 | $118.86M | +41.6% | ||
| 2000 | $83.93M | +43.2% | ||
| 1999 | $58.61M | +26.8% | ||
| 1998 | $46.22M | — |
EBITDA values are taken from Charles River's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Charles River (CRL) most recent annual EBITDA stands at $911.15M (2025) – surged 56.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Charles River EBITDA compounded at +3.5% per year, with the latest reading among the more recent periods of the dataset.
Between 2023 and 2025, Charles River EBITDA declined 11.7%, falling from $1.03B to $911.15M.
$1.03B stands as the all-time-high annual EBITDA, posted in 2023, against a low of -$355.82M during 2008.
Among 8 Healthcare peers, Charles River (CRL) ranks 9th; the peer median for EBITDA is $24.21B.
Charles River EBITDA by Year
Charles River EBITDA 2025: $911.15M
Charles River EBITDA in 2025 was $911.15M, surged 56.8% from 2024.
Charles River EBITDA 2024: $581.14M
Charles River EBITDA in 2024 was $581.14M, plunged 43.7% below 2023.
Charles River EBITDA 2023: $1.03B
Charles River EBITDA in 2023 was $1.03B, edged up 4.7% from 2022. This figure represents the highest annual value in the available history.
Charles River EBITDA 2022: $986.15M
Charles River EBITDA in 2022 was $986.15M, grew 20.2% from 2021.
Charles River EBITDA 2021: $820.16M
Charles River EBITDA in 2021 was $820.16M.
See more financial history for Charles River (CRL).
Sector peers — EBITDA
Companies in the same sector as Charles River, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Charles River's EBITDA?
- Latest reported EBITDA for Charles River (CRL) is $801.38M (period ending December 27, 2025).
How has Charles River EBITDA changed year-over-year?
- Charles River (CRL) EBITDA changed +56.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Charles River EBITDA?
- Charles River (CRL) EBITDA compound annual growth rate is +3.5% over the most recent 5 years available.
When did Charles River EBITDA hit its highest annual value?
- Charles River EBITDA reached its highest annual value of $1.03B in 2023.
What was Charles River EBITDA in 2024?
- Charles River (CRL) EBITDA in 2024 was $581.14M.
What was Charles River EBITDA in 2025?
- Charles River (CRL) EBITDA in 2025 was $911.15M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
CRL Overview
Company profile, financial tools, and key metrics
CRL Revenue Counter
Earns $127.33 every second. See per minute, hour, and day.
CRL Earnings Counter
Loses −$4.58 per second. See per minute, hour, and day.
CRL Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
CRL What If Invested
What if you had invested $1,000? See historical returns from any date.
CRL How It Makes Money
Discover visual breakdown of $4.02B in revenue — where it comes from and where it goes.
CRL Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CRL Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CRL Daily Price Character
Balanced · 51.7% historical win rate (green days). Streaks & record days.
CRL Buybacks
3.60% TTM buyback yield. Shareholder yield & SBC comparison.